Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Dimai, HP; Chandran, M; FRAX(®)Position Development Conference Members.
Official Positions for FRAX® clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
J Clin Densitom. 2011; 14(3):190-193
Doi: 10.1016/j.jocd.2011.05.011
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Dimai Hans Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The worldwide prevalence of smoking has been estimated at about 50% in men, and 10% in women, with larger variations among different populations studied. Smoking has been shown to affect many organ systems resulting in severe morbidity and increased mortality. In addition, smoking has been identified as a predictor of ten-year fracture risk in men and women, largely independent of an individual's bone mineral density. This finding has eventually lead to incorporation of this risk factor into FRAX®, an algorithm that has been developed to calculate an individual's ten-year fracture risk. However, only little, or conflicting data is available on a possible association between smoking dose, duration, length of time after cessation, type of tobacco and fracture risk, limiting this risk factor's applicability in the context of FRAX®.
- Find related publications in this database (using NLM MeSH Indexing)
- Absorptiometry, Photon -
- Algorithms -
- Diagnosis, Computer-Assisted -
- Female -
- Fractures, Bone - diagnosis
- Humans -
- Male -
- Models, Statistical -
- Osteoporotic Fractures - diagnosis
- Risk Assessment -
- Risk Factors -
- Smoking - adverse effects
- Smoking Cessation -
- Find related publications in this database (Keywords)
- Smoking
- FRAX (R)
- fracture risk
- dose-dependency
- cessation
- epidemiology